GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jiangsu Cowin Biotech Co Ltd (SHSE:688426) » Definitions » Days Sales Outstanding

Jiangsu Cowin Biotech Co (SHSE:688426) Days Sales Outstanding : 182.23 (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Jiangsu Cowin Biotech Co Days Sales Outstanding?

Jiangsu Cowin Biotech Co's average Accounts Receivable for the three months ended in Mar. 2024 was ¥57.5 Mil. Jiangsu Cowin Biotech Co's Revenue for the three months ended in Mar. 2024 was ¥28.8 Mil. Hence, Jiangsu Cowin Biotech Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 182.23.

The historical rank and industry rank for Jiangsu Cowin Biotech Co's Days Sales Outstanding or its related term are showing as below:

SHSE:688426' s Days Sales Outstanding Range Over the Past 10 Years
Min: 27.75   Med: 46.85   Max: 280.02
Current: 280.02

During the past 6 years, Jiangsu Cowin Biotech Co's highest Days Sales Outstanding was 280.02. The lowest was 27.75. And the median was 46.85.

SHSE:688426's Days Sales Outstanding is ranked worse than
87.16% of 888 companies
in the Biotechnology industry
Industry Median: 72.34 vs SHSE:688426: 280.02

Jiangsu Cowin Biotech Co's Days Sales Outstanding increased from Mar. 2023 (161.20) to Mar. 2024 (182.23).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.


Jiangsu Cowin Biotech Co Days Sales Outstanding Historical Data

The historical data trend for Jiangsu Cowin Biotech Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Cowin Biotech Co Days Sales Outstanding Chart

Jiangsu Cowin Biotech Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial 42.75 27.75 33.70 57.92 197.91

Jiangsu Cowin Biotech Co Quarterly Data
Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 161.20 255.95 327.60 376.50 182.23

Competitive Comparison of Jiangsu Cowin Biotech Co's Days Sales Outstanding

For the Biotechnology subindustry, Jiangsu Cowin Biotech Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jiangsu Cowin Biotech Co's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Jiangsu Cowin Biotech Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Jiangsu Cowin Biotech Co's Days Sales Outstanding falls into.



Jiangsu Cowin Biotech Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Jiangsu Cowin Biotech Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (128.971 + 56.837) / 2 ) / 171.341*365
=92.904 / 171.341*365
=197.91

Jiangsu Cowin Biotech Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding (Q: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (56.837 + 58.204) / 2 ) / 28.803*365 / 4
=57.5205 / 28.803*365 / 4
=182.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jiangsu Cowin Biotech Co  (SHSE:688426) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Jiangsu Cowin Biotech Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Jiangsu Cowin Biotech Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Jiangsu Cowin Biotech Co (SHSE:688426) Business Description

Traded in Other Exchanges
N/A
Address
No. 1 Yaocheng Avenue, 4th Floor, TQB Building, Jiangsu Province, Taizhou, CHN, 225300
Jiangsu Cowin Biotech Co Ltd is a national high-tech enterprise with independent intellectual property rights based in the field of life sciences. It provides innovative biological products and services to in vitro diagnostic users. The product line mainly includes molecular diagnostic raw materials enzymes, nucleic acid collection and protection agents, nucleic acid extraction kits, molecular diagnostic detection reagents and others.
Executives
Yin Jian Feng Director
Zhuang Zhi Hua Directors, senior managers

Jiangsu Cowin Biotech Co (SHSE:688426) Headlines

No Headlines